Clinical trial
Bypass Equipoise Sleeve Trial (BEST)
Active, not recruiting · Not applicable · 2 countries · Registry ID NCT02767505
What this study is about
This is nationwide registry-based randomised clinical multicenter trial in which patients will be randomised to gastric bypass (RYGB) or sleeve gastrectomy (SG). The co-primary endpoint are weight control over 5 years and the amount of severe adverse events. Additionally the investigators have predefined a number of secondary endpoints, and the trial has a sufficient number of patients to allow comparisons across subgroups.
Basic eligibility
Full registry criteria
Treatments and study arms
gastric bypass
Type of surgery: gastric bypass
Sleeve gastrectomy
Typ of surgery: sleeve gastrectomy
Primary outcomes
Non-inferiority for SG is defined as \< 5% weight difference
Superiority for SG is having 35% less serious (substantial) adverse events compared to RYGB
Study locations
21 locations were listed when this page was built. The first 40 are shown.